NASDAQ$BLFS

BioLife Solutions Inc · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

BioLife Solutions' second quarter results were announced, showing revenue growth driven by acquisitions and increased adoption of its bioproduction tools.

BioLife Solutions reported a 48% increase in total revenue for Q2 2020, reaching $9.9 million, driven by acquisitions completed in the second half of 2019. Biopreservation media accounted for 67% of the total revenue. The company gained 88 new customers in the first half of 2020 and raised $106 million year-to-date to support its consolidation strategy.

  • Total revenue increased by 48% to $9.9 million compared to Q2 2019.
  • Biopreservation media revenue was $6.7 million, representing 67% of total revenue.
  • The company gained 48 new customers during the quarter.
  • Raised gross proceeds of $86 million through an oversubscribed public offering of common stock subsequent to the quarter close.

Headline financials

Total Revenue

$9.92M

Previous: $6.7M+48.0%
EPS (adj)

-$0.01

Previous: $0.04-125.0%
GAAP gross margin

48.7%

No prior period
Non-GAAP adjusted gross margin

56.6%

Previous: 72.2%-21.6%
GAAP operating loss

$510K

No prior period
Adjusted EBITDA

$1.2M

Previous: $1.9M-36.8%
Capital Expenditures

-$251K

Previous: -$267K+6.0%
Free Cash Flow

-$16.6M

Previous: $571K-3012.6%
Net Income

-$16.4M

Previous: $838K-2054.7%
Operating Income

$44K

Previous: $919K-95.2%
Gross Profit

$5.42M

Previous: $4.74M+14.3%
Cash & Equivalents

$29.9M

Previous: $19.6M+52.4%
Total Assets

$114M

Previous: $51.7M+120.3%
Stock-Based Comp

$1.15M

Previous: $646K+77.2%

Revenue & EPS history

BioLife · Revenue · Quarterly

$9.92M

Q2 2020+48%vs Q2 2019
Beat estimate in 9 of 16 quarters(56%)
ActualEstimate

Revenue by segment

BioLife · $7.08M total across 2 segments · Q2 2020

  • Cell Processing platform
    $6.7M+4.7%
  • evo and Thaw platform
    $376K

Forward guidance

Due to uncertainty regarding the impact of COVID-19, the Company withdrew its financial guidance for 2020 on May 1, 2020.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

+0.1%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+4.3%

Avg return

30 days after

44%

22 / 50 earnings

Positive

+21.4%

Q3 2022

Best reaction

-34.5%

Q4 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.3%-2.4%+22.4%
Q4 2025+8.0%-8.1%-17.3%
Q3 2025-4.2%-4.1%-5.8%
Q2 2025+10.0%+24.4%+28.2%
Q1 2025+4.0%-1.4%+6.0%
Q4 2024+2.1%+7.6%-0.9%
Q3 2024-9.4%-21.0%+0.5%
Q2 2024+14.5%+20.3%+7.9%
Q1 2024+8.9%+25.0%+13.2%
Q4 2023+5.1%-0.5%+8.5%
Q3 2023-5.7%+3.1%+14.2%
Q2 2023-29.7%-34.9%-30.3%
Q1 2023-2.9%+3.5%+20.6%
Q4 2022+0.2%+2.7%-7.4%
Q3 2022+21.4%+14.1%-4.6%
Q2 2022+13.7%+15.7%+25.6%
Q1 2022-3.8%+1.6%+18.3%
Q4 2021-0.3%+0.9%-3.7%
Q3 2021-6.0%+5.2%-30.3%
Q2 2021-1.8%-3.9%+12.0%
Q1 2021-2.1%+4.8%+25.1%
Q4 2020+8.3%-7.8%-14.7%
Q3 2020+5.8%+0.8%+21.6%
Q2 2020+0.3%-5.4%+5.6%
Q1 2020+3.0%+10.5%+1.5%
Q4 2019-34.5%-36.7%-27.8%
Q3 2019-12.8%-8.8%-7.4%
Q2 2019-6.2%+1.1%+7.7%
Q1 2019-2.4%+4.5%+8.8%
Q4 2018+10.7%+19.4%+5.5%
Q3 2018+15.0%-8.0%-7.8%
Q2 2018-4.8%-1.0%+2.3%
Q1 2018-3.7%+7.6%+23.5%
Q4 2017-4.4%-10.2%+22.4%
Q3 2017+18.0%+21.6%+8.2%
Q2 2017+3.8%+8.2%+30.6%
Q1 2017+3.7%-1.4%+7.8%
Q4 2016-5.0%-9.5%-7.7%
Q3 2016+0.7%+2.7%+5.4%
Q2 2016-2.4%-7.7%-15.9%
Q3 2012+10.0%
Q1 2012+0.0%
Q4 2011+0.0%
Q3 2011+0.0%
Q2 2011-14.3%
Q1 2011+0.0%
Q4 2010-11.1%
Q3 2010+0.0%
Q2 2010+0.0%
Q1 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro